Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section electrically coupled to the first section and configured to be capacitively coupled to the patient's body.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section capacitively coupled to the first section and configured to be electrically coupled to the patient's body.

Abstract: The present invention seeks to prevent damage to property resulting from an animal's separation anxiety which occurs when a pet owner departs, while minimizing the period of time the dog is confined. The device incorporates an automatically releasing door of a kennel or leash. For instance, the owner of a canine can place the dog in a kennel prior to leaving his or her residence. The owner can initiate a timer on the kennel or leash, and the kennel door opens or leash releases after a pre-determined amount of time, such as 30 minutes.

Abstract: Targeted binding agents, such antibodies directed to the antigen ?V?6 and uses of such agents are described. In particular, fully human monoclonal antibodies directed to the antigen ?V?6 are disclosed. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3 are disclosed. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also disclosed.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section capacitively coupled to the first section and configured to be electrically coupled to the patient's body.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section electrically coupled to the first section and configured to be capacitively coupled to the patient's body.

Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.

Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.

Abstract: A medical lead is configured to be implanted into a patient's body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section electrically coupled to the first section and configured to be capacitively coupled to the patient's body.

Abstract: Cesarean deliveries account for greater than 30% of the deliveries in the United States. The Cesarean Delivery Incision Template is a tool which assists the surgeon in making the incision uniform in the vertical as well as horizontal plane. The Cesarean Delivery Incision Template is made of a transparent pliable material that easily conforms to the patient's body. Once in place, the surgeon can either use a marking pen to draw a line where the incision it to be placed or run a scalpel along the template to make the incision. The initial incision will be used in all subsequent cesarean deliveries on the patient making the initial placement very important.

Abstract: The present invention seeks to prevent damage to property resulting from an animal's separation anxiety which occurs when a pet owner departs, while minimizing the period of time the dog is confined. The device incorporates an automatically releasing door of a kennel or leash. For instance, the owner of a canine can place the dog in a kennel prior to leaving his or her residence. The owner can initiate a timer on the kennel or leash, and the kennel door opens or leash releases after a pre-determined amount of time, such as 30 minutes.

Abstract: Targeted binding agents, such antibodies directed to the antigen ?V?6 and uses of such agents are described. In particular, fully human monoclonal antibodies directed to the antigen ?V?6 are disclosed. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3 are disclosed. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also disclosed.

Abstract: A neurostimulation lead is configured to be implanted into a patient's body and has at least one distal electrode. The lead comprises at least one conductive filer electrically coupled to the distal electrode, a jacket for housing the conductive filer and a shield surrounding at least a portion of the filer for reducing electromagnetic coupling to the filer.

Abstract: The invention relates to targeted binding agents against ?5?1 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to ?5?1. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of ?5?1 and as diagnostics.

Abstract: The invention relates to targeted binding agents against ?5?1 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to ?5?1. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of ?5?1 and as diagnostics.

Abstract: The general goal of the present invention is to prevent damage to property resulting from the animal's separation anxiety which typically is a consequence of the pet owner's departure while minimizing the period of time the dog is confined. The most obvious objective is to restrain the animal until it calms down. A similar approach would be to reward the animal with a treat once it has calmed down. We have invented a device that incorporates an automatically releasing door of the kennel. For instance, the owner of a canine would place the dog in a kennel prior to leaving his or her residence. The owner would initiate a timer on the kennel, and the kennel door would automatically open after a pre-determined amount of time, for instance 30 minutes, or some other amount of time that was sufficient to calm the canine's emotions. After the door is automatically open, the canine would be free to exit the kennel for exercise, to access water and/or food, or otherwise explore the dwelling or its surroundings.

Abstract: A collapsible frame container assembly comprises a frame component comprising a plurality of panels connected to each other, the panels being movable relative to each other between a first substantially folded condition wherein the panels are collapsed and a second unfolded condition wherein the panels are opened to define a frame structure. Also provided is a container component comprising first and second sides defining a space therebetween of a size which can be varied according to the relative positions of the first and second sides. The frame component when in the unfolded condition and the container component are releasably coupled to each other to define a predetermined frame container assembly.

Abstract: The invention relates to targeted binding agents against KDR and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to KDR. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of KDR and as diagnostics.

Abstract: A perspiration-absorbing apparatus includes a core member which has a curvilinear shape and is removably positioned along a posterior face of the existing headwear. The apparatus further includes a liner removably engaged directly with the core member and directly positioned along a posterior face thereof. The liner includes a layer of rubber statically juxtaposed adjacent to the perspiration-absorbing layer and extending parallel thereto. The liner is wrapped about the core member in such a manner that the rubber layer lies over an anterior face of the core member while the perspiration-absorbing layer lies over a posterior face of the core member such that the core member is intercalated between the rubber and perspiration-absorbing layers respectively.

Abstract: A medical lead is configured to be implanted into a patients body and comprises a lead body, and an electrode coupled to the lead body. The electrode comprises a first section configured to contact the patient's body, and a second section electrically coupled to the first section and configured to be capacitively coupled to the patient's body.